You already do the reading.
This is where it leads.
130+ compound analyses, 10 interactive tools, and personalized protocols. Published research with real PMIDs — organized for people who verify before they act.
The problem is not knowledge. It is organization.
You understand AR binding affinity, estrogen conversion pathways, and hepatotoxicity profiles. You run bloodwork before, during, and after. You adjust protocols based on data, not opinions.
But designing a protocol still means cross-referencing dozens of studies, checking interaction data across your specific stack, and mapping bloodwork markers to compound timelines. You have the knowledge — scattered across 30 browser tabs, 4 forum threads, and a study you bookmarked six months ago.
Protocols.is organizes what you already know — and fills in the gaps with published data you can verify yourself.
Evidence has tiers. We label every one.
Published Research
PubMed-indexed studies with real PMIDs. If the study exists, we cite it. If it does not, we say so. You verify everything yourself.
Practitioner Data
Clinical observations from specialists who work with enhanced populations. Always labeled separately. You always know which tier you are reading.
Your Context
Your goals. Your compounds. Your bloodwork. Your risk tolerance. We present the data — you make the decisions. That is how it works when the reader is also the test subject.
What this is — and what it is not
- A pharmacological reference. 130+ compound analyses with mechanisms, dose-response curves, interaction data, and bloodwork markers. Every claim sourced to PubMed.
- A protocol engine. Your intake data cross-referenced against 151 compound interactions and 36 biomarkers. Personalized — not templated.
- Conflict-free. We do not sell compounds or supplements. Nobody here profits from your protocol choices. The data stays clean because there is no inventory to push.
- Not for beginners. Full pharmacological mechanisms are published because that is what informed decisions require. If you want someone to hand you a protocol without explaining the reasoning, this is not for you.
Origin
I have been self-experimenting for over a decade. I have run the compounds, pulled the bloodwork, read the full-text studies, and compared notes with people who do the same.
This is not a career pivot. It is the natural output of doing this long enough that you accumulate knowledge worth organizing.
The enhancement space has more information than ever and less signal than ever. Influencers cite studies they have not read. Coaches run cookie-cutter protocols regardless of individual response. The clinical literature is right there — but the content layer between the study and the user has been filtered through financial incentives or recycled through people who never opened the full text.
This platform exists because the data deserves better. And so do the people reading it.
— Elon Muskular, Founder
Three domains. One standard.
Every domain gets the same depth. No compound is too mainstream to analyze properly or too niche to deserve data.
Physique and Performance
Dose-response pharmacology — not dosing folklore recycled from 2016 forum posts. Mechanism of action, clinical evidence, side effect profiles, and bloodwork frameworks for every compound.
Cognitive Enhancement
Binding affinity data, receptor selectivity, and published cognitive endpoints. Not "this makes you feel sharp." If the receptor-level data does not exist, we say so.
Anti-Aging and Longevity
The frontier most enhancers reach eventually. Senolytics, NAD+ pathways, mTOR modulation, and telomere biology — same evidence standard, longer time horizon.
130+ articles. 10 interactive tools. Full pharmacokinetic dataset.
Every claim sourced. Built for people who verify before they inject.